| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.36 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |